Abstract |
Acute increases in O-linked β- N-acetylglucosamine (O-GlcNAc) levels of cardiac proteins exert protective effects against ischemia-reperfusion (I/R) injury. One strategy to rapidly increase cellular O-GlcNAc levels is inhibition of O-GlcNAcase (OGA), which catalyzes O-GlcNAc removal. Here we tested the cardioprotective efficacy of two novel and highly selective OGA inhibitors, the NAG-thiazoline derivatives NAG-Bt and NAG-Ae. Isolated perfused rat hearts were subjected to 20 min global ischemia followed by 60 min reperfusion. At the time of reperfusion, hearts were assigned to the following four groups: 1) untreated control; 2) 50 μM NAG-Bt; 3) 100 μM NAG-Bt; or 4) 50 μM NAG-Ae. All treatment groups significantly increased total O-GlcNAc levels (P < 0.05 vs. control), and this was significantly correlated with improved contractile function and reduced cardiac troponin I release (P < 0.05). Immunohistochemistry of normoxic hearts showed intense nuclear O-GlcNAc staining and higher intensity at Z-lines with colocalization of O-GlcNAc and the Z-line proteins desmin and vinculin. After I/R, there was a marked loss of both cytosolic and nuclear O-GlcNAcylation and disruption of normal striated Z-line structures. OGA inhibition largely preserved structural integrity and attenuated the loss of O-GlcNAcylation; however, nuclear O-GlcNAc levels remained low. Immunoblot analysis confirmed ∼50% loss in both nuclear and cytosolic O-GlcNAcylation following I/R, which was significantly attenuated by OGA inhibition (P < 0.05). These data provide further support for the notion that increasing cardiac O-GlcNAc levels by inhibiting OGA may be a clinically relevant approach for ischemic cardioprotection, in part, by preserving the integrity of O-GlcNAc-associated Z-line protein structures.
|
Authors | Boglarka Laczy, Susan A Marsh, Charlye A Brocks, Istvan Wittmann, John C Chatham |
Journal | American journal of physiology. Heart and circulatory physiology
(Am J Physiol Heart Circ Physiol)
Vol. 299
Issue 5
Pg. H1715-27
(Nov 2010)
ISSN: 1522-1539 [Electronic] United States |
PMID | 20833964
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Desmin
- Enzyme Inhibitors
- Thiazoles
- hexosaminidase C
- beta-N-Acetylhexosaminidases
- N-acetylglucosamine thiazoline
- Acetylglucosamine
|
Topics |
- Acetylglucosamine
(analogs & derivatives, metabolism, pharmacology, therapeutic use)
- Animals
- Desmin
(metabolism)
- Enzyme Inhibitors
(pharmacology, therapeutic use)
- Male
- Models, Animal
- Myocardial Reperfusion Injury
(metabolism, prevention & control)
- Myocardium
(metabolism)
- Rats
- Rats, Sprague-Dawley
- Thiazoles
(pharmacology, therapeutic use)
- beta-N-Acetylhexosaminidases
(antagonists & inhibitors, metabolism)
|